Table 1.
Patients’ characteristics.
| Characteristic | Number of patients (n = 75) | |
|---|---|---|
| Absolute (n) | Relative (%) | |
| Sex | ||
| Male | 28 | 37.3 |
| Female | 47 | 62.7 |
| ECOG | ||
| 0–1 | 74 | 98.7 |
| 2 | 1 | 1.3 |
| Histology | ||
| Follicular | 45 | 60.0 |
| Marginal zone | 30 | 40.0 |
| Staging | ||
| Whole body CT | 56 | 74.7 |
| PET/CT | 19 | 25.3 |
| Ann Arbor staging | ||
| I | 58 | 77.3 |
| II | 17 | 22.7 |
| B-type symptoms | ||
| Yes | 3 | 4.0 |
| No | 72 | 96.0 |
| Extranodal | ||
| Yes | 40 | 53.3 |
| No | 35 | 46.7 |
| Elevated LDH | ||
| Yes | 4 | 5.3 |
| No | 49 | 65.3 |
| Unknown | 22 | 29.3 |
| Bulky disease | 7 | 9.3% |
| FLIPI | ||
| Low risk | 34 | 75.6 |
| Low-intermediate risk | 6 | 13.3 |
| Unknown | 5 | 11.1 |
| MALT-IPI | ||
| Low risk | 15 | 50.0 |
| Low-intermediate risk | 11 | 36.7 |
| Unknown | 4 | 13.3 |
| Number of lymphoma manifestation | ||
| 1 Lymph node region | 58 | 77.3 |
| 2 LN region | 11 | 14.7 |
| ≥ 3 LN region | 6 | 8.0 |
FLIPI Follicular Lymphoma International Prognostic Index, MALT-IPI Marginal Zone Lymphoma International Prognostic Index.